Latest Revenue Performance News

IPH Limited reported solid FY25 profit growth driven by Canadian acquisitions and a promising FY26 start despite challenges in Australia and New Zealand. CEO Andrew Blattman announced his retirement for late 2026, marking a pivotal leadership transition.

Tartana Minerals has inked a non-binding Letter of Intent with Alt Resources for up to $5 million in non-dilutive financing, structured to align repayments with copper production and prices. This deal aims to optimize existing operations and fund expansion through the Mungana processing plant.

NZME Limited has upgraded its FY25 Operating EBITDA guidance, signaling stronger-than-expected financial performance despite economic headwinds. The company now expects earnings between $59 million and $62 million, up from its earlier forecast.

oOh!media has confirmed its half-year earnings for 2025 met market expectations, despite a significant non-cash impairment linked to the loss of a key Auckland Transport contract. The company maintains steady operational performance and updated guidance amid evolving market conditions.

Pengana Capital Group reported a strong turnaround in FY 2025 profitability, driven by a surge in private credit funds under management and successful new product launches. The firm’s strategic shift towards private markets is reshaping its revenue profile and balance sheet strength.

Globe International Limited reported a decline in revenue and profit for FY25, reflecting a strategic shift away from non-core brands. Despite this, the company maintains strong profitability in Australia and a solid cash position, while declaring a fully franked dividend of 20 cents per share.

Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.

IODM Limited has triggered a significant increase in its guaranteed minimum monthly revenue from its UK Education segment, reflecting a remarkable 242% growth in July 2025 compared to last year. This milestone boosts the annualised minimum payment to AUD 2.39 million, underscoring the strength of its digital accounts receivable platform.

Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.

Hydrix Limited reports steady June quarter revenues with a 10% rise from the prior quarter, supported by new contract wins and a robust $40 million project pipeline.

Rhythm Biosciences has successfully validated its ColoSTAT® colorectal cancer test, secured its first strategic partnership for Genetype, and secured $1 million in non-dilutive funding, setting the stage for a transformative FY26.

Bioxyne Limited reports a record-breaking Q4 FY25 with revenue soaring 204% year-on-year and a strategic entry into the German market through a €3.2 million manufacturing agreement.